Keywords: first, launch, usa, sb, avandia, new, data
First launch in the USA for SB's Avandia, new data show combination efficacy
Article | 16 June 1999
SmithKline Beecham says it has introduced its type 2 diabetes drugAvandia (rosiglitazone) into 40,000 pharmacies in the USA. This is the first ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
